Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
LXR ligands inhibits platelet aggregation and calcium mobilization stimulated by collagen or CRP
Formula: C21H21Cl2NO5
Ther Drug Monit
InChiKey: VXNYQUQHOUERTR-UHFFFAOYSA-N
Rifaximin Size:Solid 10 mg LXR ligands inhibits platelet aggregationRifaximin is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, for which it received orphan drug status from the U. S. Food and Drug Administration in 1998. Rifaximin interferes with transcription by binding to
US$ 49.55
US$ 53.00
US$ 190.46
US$ 133.00
US$ 477.71